Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arghya Kusum Dhar
Observed names:
Arghya Dhar,
Arghya K. Dhar,
Arghya Kusum DHAR,
ArghyaKusum Dhar
Institution:
The Neotia University
Observed institutions:
Zydus Lifesciences Limited (India),
The Neotia University,
Guru Nanak Institute of Pharmaceutical Science and Technology,
Birla Institute of Technology and Science, Pilani
ORCID:
0000-0003-1081-9143
Observed ORCID:
0000-0003-1081-9143
OpenAlex ID:
A5084811277
Citric acid: An efficient and green catalyst for rapid one pot synthesis of quinoxaline derivatives at room temperature
2011
·
Radhakrishnan Mahesh
, Arghya Kusum Dhar
, et al.
·
Chinese Chemical Letters
·
47
Antidepressant-like activity of 2-(4-phenylpiperazin-1-yl)-1, 8-naphthyridine-3-carboxylic acid (7a), a 5-HT3 receptor antagonist in behaviour based rodent models: Evidence for the involvement of serotonergic system
2013
·
Baldev Kumar Gautam
, Ankur Jindal
, et al.
·
Pharmacology Biochemistry and Behavior
·
24
Exosomes: A Novel Therapeutic Paradigm for the Treatment of Depression
2020
·
Shvetank Bhatt
, Jovita Kanoujia
, et al.
·
Current Drug Targets
·
23
Neuropharmacological evaluation of a novel 5-HT 3 receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice
2014
·
Shvetank Bhatt
, Mahesh Radhakrishnan
, et al.
·
Indian Journal of Pharmacology
·
22
PDF
Design, Synthesis and Evaluation of Antidepressant Activity of Novel 2‐Methoxy 1, 8 Naphthyridine 3‐Carboxamides as 5‐ HT 3 Receptor Antagonists
2013
·
Radhakrishnan Mahesh
, Arghya Kusum Dhar
, et al.
·
Chemical Biology & Drug Design
·
16
Antimicrobial uses of chitosan
2022
·
Arijit Mondal
, Arghya Kusum Dhar
, et al.
·
Elsevier eBooks
·
14
Piperazine Analogs of Naphthyridine‐3‐carboxamides and Indole‐2‐carboxamides: Novel 5‐HT3 Receptor Antagonists with Antidepressant‐Like Activity
2015
·
Arghya K. Dhar
, Radhakrishnan Mahesh
, et al.
·
Archiv der Pharmazie
·
14
Design, Synthesis, and Pharmacological Evaluation of Novel 2‐(4‐substituted piperazin‐1‐yl)1, 8 Naphthyridine 3‐Carboxylic Acids as 5‐ HT 3 Receptor Antagonists for the Management of Depression
2014
·
Arghya K. Dhar
, Radhakrishnan Mahesh
, et al.
·
Chemical Biology & Drug Design
·
14
Effects of Current Psychotropic Drugs on Inflammation and Immune System
2023
·
Shvetank Bhatt
, Arghya Kusum Dhar
, et al.
·
Advances in experimental medicine and biology
·
12
Ligand‐Based Design, Synthesis, and Pharmacological Evaluation of 3‐Methoxyquinoxalin‐2‐carboxamides as Structurally Novel Serotonin Type‐3 Receptor Antagonists
2012
·
Radhakrishnan Mahesh
, Thangaraj Devadoss
, et al.
·
Archiv der Pharmazie
·
12
2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carboxylic acids: Novel 5-HT3 receptor antagonists with anxiolytic-like activity in rodent behavioral models
2013
·
Radhakrishnan Mahesh
, Arghya Kusum Dhar
, et al.
·
Canadian Journal of Physiology and Pharmacology
·
11
Drug Delivery in Biotechnology: Present and Future
2024
·
Seema Yadav
, Narahari Narayan Palei
, et al.
·
Interdisciplinary biotechnological advances
·
9
Formulation of Morus alba extract loaded solid lipid nanoparticles: in silico , characterizations, and in vitro cytotoxicity study
2024
·
Narahari N. Palei
, Mohanalakshmi Sabapati
, et al.
·
Drug Development and Industrial Pharmacy
·
7
Antidepressant- and anxiolytic-like effect of novel 5-hydroxytryptamine3 receptor antagonist 2-[4-(3-chlorophenyl) piperazin-1-yl]-1,8-naphthyridine -3-carboxylic acid (7e)-: An approach using rodent behavioral antidepressant and anxiolytic test battery
2016
·
Shvetank Bhatt
, ShreyasMukund Bagal
, et al.
·
International journal of Nutrition Pharmacology Neurological Diseases
·
7
Effective Synthesis of 1,5-Disubstituted 2,1-Benzisothiazol-3(1H)-ones
2011
·
Rajendra K. Kharul
, Pinkal N. Prajapati
, et al.
·
Synthetic Communications
·
6
Carboline Hybrids as Potential Multitarget‐Directed Anti‐Alzheimer's Disease Agents: A Comprehensive Analysis of Design Strategies and Structure–Activity Relationships
2025
·
Sandipan Dash
, Arghya Kusum Dhar
·
Archiv der Pharmazie
·
3
Interplay Between Autophagy, Gut Microbiota and Inflammatory Bowel Disease
2025
·
Arghya Kusum Dhar
, Dilip Kumar Reddy Kandula
, et al.
·
Apple Academic Press eBooks
·
3
Vaccines and Oncolytic Virus for the Treatment of Lung Cancer
2024
·
Arghya Kusum Dhar
, Narahari N. Palei
, et al.
·
Springer eBooks
·
3
Immune system and diabetes mellitus
2024
·
Arghya Kusum Dhar
, Kuttiappan Anitha
, et al.
·
Elsevier eBooks
·
3
Potential of Small Molecule TAAR-1 Agonists for the Therapy of Neurodegenerative Psychosis: A Medicinal Chemistry Perspective
2026
·
Sandipan Dash
, Sheik Shehensha
, et al.
·
Mini-Reviews in Medicinal Chemistry
·
2
Small-Molecule Oligonucleotides As Smart Modality for Antiviral Therapy: A Medicinal Chemistry Perspective
2023
·
Sidhartha S Kar
, Arghya Kusum Dhar
, et al.
·
Future Medicinal Chemistry
·
2
Human Microbiome Modulation: A Potential Therapeutic Strategy for Pancreatic Cancer
2023
·
Arghya Kusum Dhar
·
Springer eBooks
·
2
PI3K/HDAC Dual Inhibitors as Potential Anticancer Therapeutics: An Insight Into Design Strategies and Structure Activity Relationships
2026
·
Sandipan Dash
, S. Shehensha
, et al.
·
ChemistrySelect
·
1
Antimicrobial and in Vitro Cytotoxicity Effect of Green Synthesized Silver Nanoparticles Using Aqueous Leaf Extract of Senna Hirsuta
2023
·
Narahari Palei
, Bhuvana MP
, et al.
·
Bulletin of Pharmaceutical Sciences Assiut
·
1
PDF
Nanocarriers and their Role in the Treatment of Breast Cancer
2023
·
Sidhartha S. Kar
, Arghya Kusum Dhar
, et al.
·
BENTHAM SCIENCE PUBLISHERS eBooks
·
1
Show more works
View as search
Works count:
47
Citation count:
259
H-index:
11
I10-index:
11
Year
Topic
Type
